封面
市場調查報告書
商品編碼
1269405

行動心電遙測設備市場(各疾病適應症:心絞痛,動脈粥狀硬化性心血管疾病,心臟衰竭,其他)-全球產業分析,規模,佔有率,成長,趨勢,預測,2023-2031年

Mobile Cardiac Telemetry Device Market (Disease Indication: Angina Pectoris, Atherosclerosis, Heart Failure, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

出版日期: | 出版商: Transparency Market Research | 英文 183 Pages | 商品交期: 2-10個工作天內

價格

行動心電遙測設備市場- 調查範圍:

TMR 的研究報告《全球行動心電遙測設備市場》為了提供2023年~2031年預測期間上關於市場指標的寶貴知識和見解,不僅探討了過去的增長趨勢,還調查了當前的增長趨勢和機會。本報告以 2023 年為基準年,2031 年為預測年。提供2017年到2031年的全球行動心電遙測設備市場收益。並刊載2023年2031年的全球行動心電遙測設備市場年複合成長率。

本報告透過廣泛研究作成。初步研究中由分析師對主要意見領袖、行業領袖和輿論製造者進行訪談,並進行大部分研究工作。二次研究則參考主要公司的產品資料、年報、新聞稿和相關文件,來掌握行動心電遙測設備市場。

該報告深入探討全球行動心電遙測設備市場的競爭格局。鎖定全球行動心電遙測設備市場活動的主要企業,並對每家公司進行了不同屬性的分析。介紹企業概要,財務狀況,最近的趨勢,SWOT等全球行動心電遙測設備市場企業的屬性。

目錄

第1章 序文

  • 市場定義和範圍
  • 市場區隔
  • 主要的調查目的
  • 調查亮點

第2章 前提條件與調查手法

第3章 摘要整理:全球市場

第4章 市場概要

  • 簡介
    • 疾病適應定義
    • 產業的演進/發展
  • 概要
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
  • 全球市場的分析與預測,2017年~2031年

第5章 主要洞察

  • 技術的進步
  • 法律規章的分析
  • 疾病的發生率和盛行率
  • COVID-19影響分析

第6章 全球市場分析·預測:各應用領域

  • 簡介和定義
  • 主要的發現與發展
  • 市場價值預測:各應用領域,2017年~2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場魅力分析:各應用領域

第7章 全球市場分析·預測:各疾病各適應症

  • 簡介和定義
  • 主要調查結果/發展情形
  • 市場價值預測:疾病各適應症,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場魅力:疾病各適應症

第8章 全球市場分析·預測:各終端用戶

  • 簡介&定義
  • 主要調查結果·發展情形
  • 市場規模預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家護理設施
    • 其他
  • 市場魅力分析:各終端用戶

第9章 全球市場分析·預測:各地區

  • 主要調查結果
  • 市場價值預測:各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲地區
  • 市場魅力分析:各地區

第10章 北美市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各應用領域,2017-2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場價值預測:適應各疾病,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家醫療設施
    • 其他
  • 市場價值預測:各國,2017-2031年
    • 美國
    • 加拿大
  • 市場魅力分析
    • 各應用領域
    • 各疾病各適應症
    • 各終端用戶
    • 各國

第11章 歐洲市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各應用領域,2017-2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場價值預測:適應各疾病,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家醫療設施
    • 其他
  • 市場價值預測:各國/小各地區,2017-2031年
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 其他歐洲
  • 市場魅力分析
    • 各應用領域
    • 各疾病各適應症
    • 各終端用戶
    • 各國/子地區

第12章 亞太地區的市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各應用領域,2017-2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場價值預測:適應各疾病,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家醫療設施
    • 其他
  • 市場價值預測:各國和各地,2017-2031年
    • 中國
    • 日本
    • 印度
    • 澳洲·紐西蘭
    • 其他亞太地區
  • 市場魅力分析
    • 各應用領域
    • 各疾病各適應症
    • 各終端用戶
    • 各國/子地區

第13章 南美的市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各應用領域,2017-2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場價值預測:適應各疾病,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家醫療設施
    • 其他
  • 市場價值預測:各國/小各地區,2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美國家地區
  • 市場魅力分析
    • 各應用領域
    • 各疾病各適應症
    • 各終端用戶
    • 各國/子地區

第14章 中東·非洲的市場分析·預測

  • 簡介
    • 主要調查結果
  • 市場價值預測:各應用領域,2017-2031年
    • 導線為基礎的
    • 貼片為基礎的
  • 市場價值預測:適應各疾病,2017-2031年
    • 心絞痛
    • 動脈粥狀硬化性心血管疾病
    • 心臟衰竭
    • 其他
  • 市場價值預測:各終端用戶,2017-2031年
    • 醫院
    • 專門診所
    • 診斷中心
    • 居家醫療設施
    • 其他
  • 市場價值預測:各國/小各地區,2017-2031年
    • 巴西
    • 墨西哥
    • 其他南美國家地區
  • 市場魅力分析
    • 各應用領域
    • 各疾病各適應症
    • 各終端用戶
    • 各國/子地區

第15章 競爭情形

  • 市場競爭者-競爭矩陣(企業各層級,不同企業規模)
  • 市場佔有率分析:各企業, 2022年
  • 企業簡介
    • BioTelemetry, Inc.
    • ScottCare
    • Biotricity Inc.
    • Welch Allyn
    • Applied Cardiac Systems, Inc.
    • Medicomp, Inc.
    • Preventice Solutions
    • Telerhythmics LLC
    • Zoll Medical Corporation
    • iRhythm Technologies, Inc.
Product Code: TMRGL62667

Mobile Cardiac Telemetry Device Market - Scope of Report:

TMR's report on the global mobile cardiac telemetry device market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global mobile cardiac telemetry device market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global mobile cardiac telemetry device market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the mobile cardiac telemetry device market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global mobile cardiac telemetry device market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global mobile cardiac telemetry device market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global mobile cardiac telemetry device market.

The report delves into the competitive landscape of the global mobile cardiac telemetry device market. Key players operating in the global mobile cardiac telemetry device market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global mobile cardiac telemetry device market profiled in this report.

Key Questions Answered in Global Mobile Cardiac Telemetry Device Market Report:

  • What is the sales/revenue generated by mobile cardiac telemetry device across all regions during the forecast period?
  • What are the opportunities in the global mobile cardiac telemetry device market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Mobile Cardiac Telemetry Device Market - Research Objectives and Research Approach:

The comprehensive report on the global mobile cardiac telemetry device market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global mobile cardiac telemetry device market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global mobile cardiac telemetry device market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Mobile Cardiac Telemetry Device Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Disease Indication Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Technological Advancement
  • 5.2. Regulatory Analysis
  • 5.3. Disease Incidence and Prevalence
  • 5.4. COVID-19 Impact Analysis

6. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast, by Application, 2017 - 2031
    • 6.3.1. Lead-based
    • 6.3.2. Patch-based
  • 6.4. Market Attractiveness Analysis, by Application

7. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Disease Indication

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 7.3.1. Angina Pectoris
    • 7.3.2. Atherosclerosis
    • 7.3.3. Heart Failure
    • 7.3.4. Others
  • 7.4. Market Attractiveness, by Disease Indication

8. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast, by End-user, 2017-2031
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Diagnostic Centers
    • 8.3.4. Home Care Settings
    • 8.3.5. Others
  • 8.4. Market Attractiveness Analysis, by End-user

9. Global Mobile Cardiac Telemetry Device Market Analysis and Forecast, by Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast, by Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness Analysis, by Region

10. North America Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast, by Application, 2017-2031
    • 10.2.1. Lead-based
    • 10.2.2. Patch-based
  • 10.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 10.3.1. Angina Pectoris
    • 10.3.2. Atherosclerosis
    • 10.3.3. Heart Failure
    • 10.3.4. Others
  • 10.4. Market Value Forecast, by End-user, 2017-2031
    • 10.4.1. Hospitals
    • 10.4.2. Specialty Clinics
    • 10.4.3. Diagnostic Centers
    • 10.4.4. Home Care Settings
    • 10.4.5. Others
  • 10.5. Market Value Forecast, by Country, 2017-2031
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Application
    • 10.6.2. By Disease Indication
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Application, 2017-2031
    • 11.2.1. Lead-based
    • 11.2.2. Patch-based
  • 11.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 11.3.1. Angina Pectoris
    • 11.3.2. Atherosclerosis
    • 11.3.3. Heart Failure
    • 11.3.4. Others
  • 11.4. Market Value Forecast, by End-user, 2017-2031
    • 11.4.1. Hospitals
    • 11.4.2. Specialty Clinics
    • 11.4.3. Diagnostic Centers
    • 11.4.4. Home Care Settings
    • 11.4.5. Others
  • 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Spain
    • 11.5.5. Italy
    • 11.5.6. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Application
    • 11.6.2. By Disease Indication
    • 11.6.3. By End-user
    • 11.6.4. By Country/Sub-region

12. Asia Pacific Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Application, 2017-2031
    • 12.2.1. Lead-based
    • 12.2.2. Patch-based
  • 12.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 12.3.1. Angina Pectoris
    • 12.3.2. Atherosclerosis
    • 12.3.3. Heart Failure
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by End-user, 2017-2031
    • 12.4.1. Hospitals
    • 12.4.2. Specialty Clinics
    • 12.4.3. Diagnostic Centers
    • 12.4.4. Home Care Settings
    • 12.4.5. Others
  • 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.5.1. China
    • 12.5.2. Japan
    • 12.5.3. India
    • 12.5.4. Australia & New Zealand
    • 12.5.5. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Application
    • 12.6.2. By Disease Indication
    • 12.6.3. By End-user
    • 12.6.4. By Country/Sub-region

13. Latin America Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Application, 2017-2031
    • 13.2.1. Lead-based
    • 13.2.2. Patch-based
  • 13.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 13.3.1. Angina Pectoris
    • 13.3.2. Atherosclerosis
    • 13.3.3. Heart Failure
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by End-user, 2017-2031
    • 13.4.1. Hospitals
    • 13.4.2. Specialty Clinics
    • 13.4.3. Diagnostic Centers
    • 13.4.4. Home Care Settings
    • 13.4.5. Others
  • 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Application
    • 13.6.2. By Disease Indication
    • 13.6.3. By End-user
    • 13.6.4. By Country/Sub-region

14. Middle East & Africa Mobile Cardiac Telemetry Device Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Application, 2017-2031
    • 14.2.1. Lead-based
    • 14.2.2. Patch-based
  • 14.3. Market Value Forecast, by Disease Indication, 2017-2031
    • 14.3.1. Angina Pectoris
    • 14.3.2. Atherosclerosis
    • 14.3.3. Heart Failure
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by End-user, 2017-2031
    • 14.4.1. Hospitals
    • 14.4.2. Specialty Clinics
    • 14.4.3. Diagnostic Centers
    • 14.4.4. Home Care Settings
    • 14.4.5. Others
  • 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.5.1. Brazil
    • 14.5.2. Mexico
    • 14.5.3. Rest of Latin America
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Application
    • 14.6.2. By Disease Indication
    • 14.6.3. By End-user
    • 14.6.4. By Country/Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (by tier and size of companies)
  • 15.2. Market Share Analysis, by Company, 2022
  • 15.3. Company Profiles
    • 15.3.1. BioTelemetry, Inc.
      • 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.1.2. Test Application Portfolio
      • 15.3.1.3. Financial Overview
      • 15.3.1.4. SWOT Analysis
      • 15.3.1.5. Strategic Overview
    • 15.3.2. ScottCare
      • 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.2.2. Test Application Portfolio
      • 15.3.2.3. Financial Overview
      • 15.3.2.4. SWOT Analysis
      • 15.3.2.5. Strategic Overview
    • 15.3.3. Biotricity Inc.
      • 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.3.2. Test Application Portfolio
      • 15.3.3.3. Financial Overview
      • 15.3.3.4. SWOT Analysis
      • 15.3.3.5. Strategic Overview
    • 15.3.4. Welch Allyn
      • 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.4.2. Test Application Portfolio
      • 15.3.4.3. Financial Overview
      • 15.3.4.4. SWOT Analysis
      • 15.3.4.5. Strategic Overview
    • 15.3.5. Applied Cardiac Systems, Inc.
      • 15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.5.2. Test Application Portfolio
      • 15.3.5.3. Financial Overview
      • 15.3.5.4. SWOT Analysis
      • 15.3.5.5. Strategic Overview
    • 15.3.6. Medicomp, Inc.
      • 15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.6.2. Test Application Portfolio
      • 15.3.6.3. Financial Overview
      • 15.3.6.4. SWOT Analysis
      • 15.3.6.5. Strategic Overview
    • 15.3.7. Preventice Solutions
      • 15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.7.2. Test Application Portfolio
      • 15.3.7.3. Financial Overview
      • 15.3.7.4. SWOT Analysis
      • 15.3.7.5. Strategic Overview
    • 15.3.8. Telerhythmics LLC
      • 15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.8.2. Test Application Portfolio
      • 15.3.8.3. Financial Overview
      • 15.3.8.4. SWOT Analysis
      • 15.3.8.5. Strategic Overview
    • 15.3.9. Zoll Medical Corporation
      • 15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.9.2. Test Application Portfolio
      • 15.3.9.3. Financial Overview
      • 15.3.9.4. SWOT Analysis
      • 15.3.9.5. Strategic Overview
    • 15.3.10. iRhythm Technologies, Inc.
      • 15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 15.3.10.2. Test Application Portfolio
      • 15.3.10.3. Financial Overview
      • 15.3.10.4. SWOT Analysis
      • 15.3.10.5. Strategic Overview

List of Tables

  • Table 1: Global overview of Surgical Mobile Cardiac Telemetry Device
  • Table 2: Regional overview of Surgical Mobile Cardiac Telemetry Device
  • Table 4: North America Overview of Surgical Mobile Cardiac Telemetry Device
  • Table 4: Asia Pacific overview of Surgical Mobile Cardiac Telemetry Device
  • Table 5: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 6: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 7: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 8: Global Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Region, 2023-2031
  • Table 9: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country, 2023-2031
  • Table 10: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 11: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 12: North America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 13: Europe Surgical Mobile Cardiac Telemetry Device Revenue (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 14: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 15: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 16: Europe Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 17: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 18: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 19: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 20: Asia Pacific Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 21: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 22: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 23: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 24: Latin America Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031
  • Table 25: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031
  • Table 26: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Application, 2023-2031
  • Table 27: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by Disease Indication, 2023-2031
  • Table 28: Middle East & Africa Surgical Mobile Cardiac Telemetry Device Value (US$ Mn) Forecast, by End-user, 2023-2031

List of Figures

  • Figure 01: Global Mobile Cardiac Telemetry Device Market
  • Figure 02: Global Mobile Cardiac Telemetry Device Market Size (US$ Mn) Forecast, 2017-2031
  • Figure 03: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication (2022)
  • Figure 04: Global Mobile Cardiac Telemetry Device Market Value Share, by Application (2022)
  • Figure 05: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user (2022)
  • Figure 06: Global Mobile Cardiac Telemetry Device Market Value Share, by Region (2022)
  • Figure 07: Global Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 08: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 09: Global Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 10: Global Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 11: Global Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 12: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 13: Global Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 14: Global Mobile Cardiac Telemetry Device Market Value Share, by Region, 2023-2031
  • Figure 15: Global Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Region, 2023-2031
  • Figure 16: North America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 17: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 18: North America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 19: North America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 20: North America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 21: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 22: North America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 23: North America Mobile Cardiac Telemetry Device Market Value Share, by Country, 2023-2031
  • Figure 24: North America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country, 2023-2031
  • Figure 25: Europe Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 26: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 27: Europe Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 28: Europe Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 29: Europe Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 30: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 31: Europe Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 32: Europe Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 33: Europe Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 34: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 35: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 36: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 37: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 38: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 39: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 40: Asia Pacific Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 41: Asia Pacific Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 42: Asia Pacific Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 43: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 44: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 45: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 46: Latin America Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 47: Latin America Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 48: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 49: Latin America Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 50: Latin America Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 51: Latin America Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 52: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Application, 2022 and 2031
  • Figure 53: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Application, 2023-2031
  • Figure 54: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Disease Indication, 2022 and 2031
  • Figure 55: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness, by Disease Indication, 2023-2031
  • Figure 56: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by End-user, 2022 and 2031
  • Figure 57: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by End-user, 2023-2031
  • Figure 58: Middle East & Africa Mobile Cardiac Telemetry Device Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 59: Middle East & Africa Mobile Cardiac Telemetry Device Market Value Share, by Country/Sub-region, 2022-2031
  • Figure 60: Middle East & Africa Mobile Cardiac Telemetry Device Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
  • Figure 61: Global Mobile Cardiac Telemetry Device Market Share Analysis, by Company, 2022 (Estimated)
  • Figure 62: Global Mobile Cardiac Telemetry Device Market Performance, by Company, 2022
  • Figure 63: Competition Matrix